Press Release Distribution
 

Members Login  |  Register  |  Why Join?   Subscribe to Newsletter Newsletter   RSS Feeds RSS Feeds

Video Releases    |    Pricing & Distribution Plans    |    Today's News    |    News By Category    |    News By Date    |    Business Directory
All Press Releases for February 25, 2009 »
RSS Feeds RSS Feed     Print this news Printer Friendly     Email this news Email It    Create PDF PDF Version    Bookmark del.icio.us    Diggs



Survey by BioScience Laboratories Finds 68% of Subject Pool Pre-qualified for Upcoming Phase I Clinical Trials
The results of a recent survey by BioScience Laboratories to prepare its subject base for upcoming Phase I clinical trials, indicated that 68% of its active subjects pre-qualify for Phase I clinical trials. 
x-small text small text medium text large text


    BOZEMAN, MT, February 25, 2009 /24-7PressRelease/ -- The results of a recent survey by BioScience Laboratories to prepare its subject base for upcoming Phase I clinical trials, indicated that 68% of its active subjects pre-qualify for Phase I clinical trials. To be considered pre-qualified, subjects must be at least 18 years of age, have a BMI between 18 and 30, be physically willing and able to participate, and not be taking any prescription medications. BioScience Laboratories recruits its subjects from a population of over 100,000 in Southwest Montana. This population includes persons of a variety of ethnic origins -- Asian, Caucasian, Latino, Native American and others -- with a median age of 25.

BioScience Laboratories, a Contract Research Organization for Phase I Clinical Trials, including bioavailability and bioequivalence studies, has performed over 1,500 clinical studies ranging in size from 40 to 400 subjects during its eighteen year history. BioScience Laboratories maintains a GCP-compliant clinical laboratory that has been successfully audited by both our clients and the FDA and has filled studies in as quickly as four hours. To protect the well-being and health of the subjects, BioScience Laboratories employs the services of the Gallatin Institutional Review Board, which is comprised of healthcare and other professionals who review all clinical study protocols. This board is registered and has been audited by the Food and Drug Administration.

For additional information, contact:
Sabrina Bakich
BioScience Laboratories, Inc.
1-877-858-2754
FAX 406-586-7930
sbakich@biosciencelabs.com
www.biosciencelabs.com

About BioScience Laboratories, Inc.

BioScience Laboratories, Inc. was founded in 1991 in Bozeman, MT, to provide antimicrobial product testing and result interpretation grounded in science. Bioscience Laboratories Inc. strives to assist its clients in strengthening their current market positions through product testing and aid in the development of new products and new markets. Today, BioScience Laboratories offers state-of-the art clinical study and laboratory services and guidance regarding federal regulatory agency requirements for the healthcare, pharmaceutical, personal care and consumer products markets.


---
Press release service and press release distribution provided by http://www.24-7pressrelease.com


# # #

Press Release Keywords:
Read more Press Releases from Sabrina Bakich:

Press Release Service & Press Release Distribution News Supplied By 24-7PressRelease.com
Press Release Contact Information:
Sabrina Bakich
BioScience Laboratories, Inc.

Marketing Manager
300 N Willson Avenue
Bozeman, MT
USA 59715
Voice: 406-587-5735
Fax: 406-586-7930
E-Mail: Email us Here
Website: Visit Our Website
Disclaimer:
If you have any questions regarding information in this press release, please contact the person listed in the contact module of this page. Please do not attempt to contact 24-7 Press Release. We are unable to assist you with any information regarding this release. 24-7 Press Release disclaims any content contained in this press release. Please see our complete Terms of Service disclaimer for more information.